159 related articles for article (PubMed ID: 38556593)
1. CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer.
Ancona A; Telegrafo M; Fella RR; Iamele D; Cantore S; Moschetta M
Eur Radiol Exp; 2024 Apr; 8(1):32. PubMed ID: 38556593
[TBL] [Abstract][Full Text] [Related]
2. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast.
Giannotti E; Van Nijnatten TJA; Chen Y; Bicchierai G; Nori J; De Benedetto D; Lalji U; Lee AHS; James J
Clin Radiol; 2024 Jun; 79(6):e799-e806. PubMed ID: 38383254
[TBL] [Abstract][Full Text] [Related]
3. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
5. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
Åhsberg K; Gardfjell A; Nimeus E; Rasmussen R; Behmer C; Zackrisson S; Ryden L
World J Surg Oncol; 2020 May; 18(1):100. PubMed ID: 32438917
[TBL] [Abstract][Full Text] [Related]
6. Performance of contrast-enhanced mammography for detecting multifocal and multicentric breast cancer and evaluating tumour size, and implications for surgical management: Early experience in a tertiary centre.
Thanh Ha Nguyen M; Varma N; Lan Cheong Wah D; Chew R; Botha T; Kouloyan-Ilic S; Paiva J
J Med Imaging Radiat Oncol; 2024 Mar; 68(2):141-149. PubMed ID: 38146085
[TBL] [Abstract][Full Text] [Related]
7. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
[TBL] [Abstract][Full Text] [Related]
8. Multireader comparison of contrast-enhanced mammography versus the combination of digital mammography and digital breast tomosynthesis in the preoperative assessment of breast cancer.
Girometti R; Linda A; Conte P; Lorenzon M; De Serio I; Jerman K; Londero V; Zuiani C
Radiol Med; 2021 Nov; 126(11):1407-1414. PubMed ID: 34302599
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
[TBL] [Abstract][Full Text] [Related]
12. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced dedicated breast CT: initial clinical experience.
Prionas ND; Lindfors KK; Ray S; Huang SY; Beckett LA; Monsky WL; Boone JM
Radiology; 2010 Sep; 256(3):714-23. PubMed ID: 20720067
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced mammography in breast cancer screening.
Coffey K; Jochelson MS
Eur J Radiol; 2022 Nov; 156():110513. PubMed ID: 36108478
[TBL] [Abstract][Full Text] [Related]
15. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
Lobbes MBI; Heuts EM; Moossdorff M; van Nijnatten TJA
Eur J Radiol; 2021 Sep; 142():109883. PubMed ID: 34358810
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study.
Cozzi A; Schiaffino S; Fanizza M; Magni V; Menicagli L; Monaco CG; Benedek A; Spinelli D; Di Leo G; Di Giulio G; Sardanelli F
Eur Radiol; 2022 Nov; 32(11):7388-7399. PubMed ID: 35648209
[TBL] [Abstract][Full Text] [Related]
17. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced cone-beam breast-CT: Analysis of optimal acquisition time for discrimination of breast lesion malignancy.
Uhlig J; Fischer U; Surov A; Lotz J; Wienbeck S
Eur J Radiol; 2018 Feb; 99():9-16. PubMed ID: 29362157
[TBL] [Abstract][Full Text] [Related]
20. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
